As of September 30, 2024, Aesculap Implant Systems (AIS) will no longer market and distribute products from the Spine portfolio in the United States. Strategic external partnership options for the spine product portfolio, including our unique activL technology, are actively being explored to continue to bring this technology to patients and clinicians after September 30, 2024.
Please contact your AIS sales representative with further questions.
Treatment of the Thoracolumbar Spine
As the incidences of spinal pathologies such as degenerative disc disease or deformity are rising, Aesculap Implant Systems' anticipates these trends and invests in the ongoing development of spinal solutions for the treatment and stabilization of the thoracolumbar spine. Aesculap’s innovative product portfolio provides treatment options for spinal disease, degeneration and trauma from T1 through the sacrum. Through cutting-edge products and solutions for the most demanding thoracolumbar surgical cases in the form of implant systems, instrumentation and interbody devices.